Combination of EGFR signalling pathway inhibitors and prevention of resistance.
Cornelissen
Bart
B
MRC/CRUK Gray Institute for Radiation Biology and Biology Radiobiology Research Institute, Churchill Hospital, Headington, Oxford, United Kingdom. bart.cornelissen@rob.ox.ac.uk
D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism*; D020929:Mitogen-Activated Protein Kinase Kinases / Q000037:antagonists & inhibitors*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*
D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors; D020929:Mitogen-Activated Protein Kinase Kinases